Cefazolin for the Treatment of Central Nervous System Infections
- PMID: 37724584
- DOI: 10.1093/cid/ciad559
Cefazolin for the Treatment of Central Nervous System Infections
Conflict of interest statement
Potential conflicts of interest. The author reports payments (to self) from contracts with the American College of Physicians (ACP Medical Knowledge Self-Assessment Program Deputy Editor), IDSA Foundation (Alzheimer's Review Committee Co-Chair), and Clinical Infectious Diseases (State-of-the-Art Reviews section co-editor); royalties from UpToDate (section editor for Central Nervous System Infections) and Elsevier (book editor for Medicine—A Competency Based Companion); consulting fees from CURE Drug Repurposing Collaboratory (CRDC) Meningitis Working Group; payment for speaking/educational events from Infectious Diseases Board Review and Infectious Diseases in Adults Course at Massachusetts General Hospital; participation on a data and safety monitoring board for a phase 1/2 study of pembrolizumab and M032; and unpaid positions on the Advisory Committee for the Sigal Family Professorship in Humanism and the Technical Advisory Committee for the National Institutes of Health Clinical Center. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment on
-
Antibiotic Myths for the Infectious Diseases Clinician.Clin Infect Dis. 2023 Oct 13;77(8):1120-1125. doi: 10.1093/cid/ciad357. Clin Infect Dis. 2023. PMID: 37310038
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical